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Abstract 33 
Background Predictors of outcome in lateral epicondylalgia, which is mainly characterised 34 
as a mechanical hyperalgesia, are largely limited to socio-demographic and symptomatic 35 
factors. Quantitative sensory testing is used to study altered pain processing in various 36 
chronic pain conditions and may be of prognostic relevance. 37 
Methods The predictive capacity of early measures of physical and psychological 38 
impairment on pain and disability and mechanical hyperalgesia, were examined using data 39 
from 41 patients assigned to placebo in a prospective randomised controlled trial of unilateral 40 
lateral epicondylalgia. Quantitative sensory testing (pressure, cold pain thresholds), motor 41 
function (pain free grip) and psychological factors (Tampa scale of kinesiophobia, Hospital 42 
anxiety and depression scale) were measured at baseline. The outcome measures were the 43 
Patient Rated Tennis Elbow Evaluation (PRTEE) scale and pressure pain threshold (PPT) 44 
measured by digital algometry at the affected elbow. Backwards stepwise linear regression 45 
was used to predict PRTEE and PPT scores at two and twelve months.  46 
Results Cold pain threshold was the only consistent predictor for both PRTEE (p<0.034) and 47 
PPT (p<0.048). Initial PRTEE was the strongest single predictor of PRTEE at 2 months, 48 
while female sex was the strongest single predictor of PPT (p<0.002). At one year, final 49 
models explained 9 to 52% of the variability in pain and disability and mechanical 50 
hyperalgesia respectively. 51 
Discussion Early assessment of cold pain threshold could be a useful clinical tool to help 52 
identify patients at risk of poorer outcomes and might provide direction for future research 53 
into mechanism-based treatment approaches for these patients. 54 
  55 
Introduction  56 
 57 
Lateral epicondylalgia (LE) or tennis elbow is a common musculoskeletal condition with a 58 
population of prevalence 1-4%.1, 2  Considerable variability is found for literature on its 59 
prognosis, with typical durations ranging from six months to years, and differing opinions on 60 
the likelihood of recurrence.3  The ability to predict which patients will develop chronic pain 61 
is important so that appropriate early management can be targeted to these patients. 62 
Investigation of prognostic factors associated with LE has previously focused on socio-63 
demographic and symptomatic factors, many of which have not demonstrated consistency 64 
across independent studies3 or are not readily amenable to secondary and tertiary 65 
intervention.4  The role of other physical and psychological factors on the prognosis of LE 66 
has not been addressed.  67 
 68 
Over the last couple of decades, quantitative sensory testing (QST) has sometime been used  69 
as a potential clinical method for diagnosis and monitoring of pain processing and its 70 
alterations in patients with chronic pain.5 A common technique involves application of 71 
noxious stimuli, such as mechanical or thermal, to the patient under standardised conditions 72 
and deriving the threshold for the transition to pain (i.e. the pain threshold). As well as the 73 
tolerance and the intensity of the noxious stimulation. Cross-sectional evaluation of QST in 74 
patients with LE has revealed widespread mechanical hyperalgesia,6-8 and bilateral cold 75 
hyperalgesia in unilateral LE, notably in a subpopulation of severe LE.8, 9 The presence of 76 
generalised hyperalgesia, evident in a large number of other chronic pain conditions, 77 
including whiplash,10 back pain,11 fibromyalgia12 and patellofemoral pain syndrome,13 is 78 
cited as a sign of supraspinal central sensitisation.5 Pre-operative hyperalgesia has been 79 
shown to increase the risk of subsequent post-operative chronic pain,5 while the predictive 80 
capacity of cold pain4, 14 and pressure pain thresholds15 have been demonstrated following 81 
whiplash injury.  To date no studies have evaluated the prognostic capacity of QST measures 82 
on pain and disability in patients with LE. In addition, serial assessment of mechanical 83 
hyperalgesia, a characteristic feature of LE,8 might be a clinically useful method of 84 
monitoring development of chronic pain, hence study of factors associated with its 85 
persistence is warranted. 86 
 87 
There is also budding interest in psychological factors in chronic musculoskeletal conditions.  88 
Fear of movement or injury has been identified as a predictor of disability in acute and 89 
chronic low back pain16 and arm, neck and shoulder pain.17 Depression commonly co-occurs 90 
with chronic pain and may affect a patients' prognosis and hinder recovery.18 Higher levels of 91 
depression and anxiety were associated with pain and disability in a small study of LE,19 92 
though this was not substantiated in a larger study.8 Simultaneous measurement of QST and 93 
psychological factors may allow exploration of the relative predictive capacity of these 94 
possibly interacting factors.20 95 
 96 
This study aimed to investigate the predictive capacity of early physical and psychological 97 
measures on short and long term outcomes of pain and disability and mechanical 98 
hyperalgesia at the affected elbow.  99 
 100 
Methods 101 
Study design 102 
This was a post-hoc analysis of a previously reported twelve month prospective study of the 103 
clinical efficacy of corticosteroid injection and physiotherapy interventions in 165 104 
participants with lateral epicondylalgia.21, 22 The methodology and results of this trial are 105 
presented in detail elsewhere.21, 22 In summary, consenting patients were randomly assigned 106 
to either a placebo intervention (described below) or one of three conservative interventions 107 
(corticosteroid injection, physiotherapy or their combination). Due to significant effects of 108 
the active treatments on outcomes, only participants randomised to placebo (n=41) were 109 
included in the current prognostic analysis. Participants attended the research unit to 110 
complete all questionnaires and assessments by a blinded outcome assessor. Ethical approval 111 
was  granted  by  The  University  of  Queensland’s  medical  research  ethics  committee  and  all  112 
participants provided written informed consent.  113 
 114 
Participants 115 
Trial participants were recruited via community advertisement from Brisbane, Australia 116 
between August 2008 and May 2010 and were screened for eligibility via telephone and 117 
physical examination. Inclusion criteria were unilateral lateral elbow pain greater than six 118 
weeks duration, over the lateral humeral epicondyle of severity greater than 30 on a 100mm 119 
visual analogue scale (VAS), provoked by at least two of: gripping, palpation, resisted wrist 120 
or middle finger extension or stretching of forearm extensor muscles with reduced pain-free 121 
grip. Exclusion criteria were injection (preceding six months); course of physiotherapy 122 
(preceding three months); concomitant neck or other arm pain necessitating treatment or 123 
preventing participation in usual work or recreational activities (preceding six months); 124 
symptoms suggesting radicular, neurological or systemic arthritic conditions; pregnancy; 125 
breastfeeding; or contraindication to injection.  126 
 127 
Placebo assigned participants received a single, blinded injection of a negligible volume 128 
(0.5ml) isotonic (0.9%) saline within 10 days of randomisation. Participants received 129 
standardised advice and could use an analgesic or anti-inflammatory medication, heat or cold 130 
packs, or braces as needed, but were discouraged from seeking treatments other than those 131 
assigned during the one year follow up period.  132 
 133 
Measures 134 
The two outcome measures (dependent variables) in this study were pain and disability, as 135 
measured by the Patient-rated tennis elbow evaluation (PRTEE) and mechanical 136 
hyperalgesia, as measured by pressure pain threshold (PPT) over the affected lateral elbow. 137 
The independent variables were measures of both physical and psychological impairment 138 
recorded at baseline as outlined below. Gender and duration were also included since these 139 
have been highlighted as potential predictors of outcome.23-25  140 
 141 
Pain and disability 142 
The PRTEE is a reliable, reproducible, and sensitive instrument for assessment of pain and 143 
disability in LE.26, 27 It has been found to be at least as sensitive to change as other 144 
measurement tools, and is proposed as the standard primary outcome measure in research of 145 
LE.26 Items are scored on a series of 10-point Likert scales, with five items used to assess 146 
pain and ten items used to assess function. Pain and disability subscales contribute equally to 147 
the overall score, ranging from 0 (no pain or disability) to100 (worst pain or disability).  148 
 149 
Quantitative sensory testing 150 
Pressure and cold pain thresholds were measured over the affected lateral elbow, using 151 
established protocols.22, 28 Previous studies have confirmed the reliability of these measures 152 
(ICCs > 0.86).6, 8 PPT was measured using a digital pressure algometer (Somedic AB, Farsta, 153 
Sweden), with a probe size 1cm2, applied perpendicular to the tissues at the tendinous origin 154 
of the wrist extensor muscles, at a rate of 40kPa/s. In  order  to  capture  an  individual’s  pain  155 
threshold, participants were instructed to indicate when the sensation changed from a 156 
comfortable sensation to the first onset of pain. Cold pain threshold was measured using the 157 
Thermotest system (Somedic AB, Farsta, Sweden). From a baseline temperature of 30⁰C, the 158 
thermode was decreased at a rate of 1⁰C/s until the first sensation of pain was perceived or a 159 
minimum cut-off temperature of 5⁰C was reached. Each QST stimulus was applied three 160 
times and the mean value used for all analyses. 161 
 162 
Pain free grip 163 
Pain free grip is established as a convenient and reliable (ICC>0.97) assessment tool, which 164 
correlates more strongly with disability and perceived improvement than maximal grip 165 
strength in LE populations.29-31 It was measured on the affected arm using a digital grip 166 
dynamometer with variable hand position (MIE, Medical Research, UK). The participant was 167 
positioned in supine position with the arm in relaxed extension and forearm in pronation, 168 
such that the palm of the hand faced down on the plinth. Participants squeezed the 169 
dynamometer at a consistent rate and stopped the instant pain was experienced. Three 170 
recordings were taken and the mean value used in analyses.  171 
 172 
Psychological measures 173 
The hospital anxiety and depression scale (HADS) is a short self-assessment questionnaire 174 
that measures anxiety and depression, and has been demonstrated to be an appropriate 175 
measure in musculoskeletal pain.32 It consists of 14 items rated on 4-point scales with a total 176 
score ranging from 0-42, greater scores indicating greater anxiety and depression. The Tampa 177 
scale of kinesiphobia (TSK) was used to quantify kinesiophobia, defined as an irrational, and 178 
debilitating fear of physical movement and activity resulting from a feeling of vulnerability to 179 
painful injury or re-injury.33 The scale is based on the model of fear avoidance, fear of work 180 
related activities, fear of movement and fear of re-injury.33 The 11 item questionnaire, which 181 
has been validated in upper extremity disorders, consists of 11 items rated on 4-point Likert 182 
scales with a total score ranging from 11-44, greater scores indicating greater 183 
kinesiophobia.34  184 
 185 
 186 
Data analysis 187 
Statistical analyses were performed by intention to treat using SPSS (Version 20.0). Baseline 188 
data for each potential prognostic variable were presented as means and standard deviations 189 
for continuous data, and numbers and percentages for categorical data. Independent t tests 190 
and Pearson χ2 tests were used to evaluate whether continuous and categorical baseline 191 
variables differed between participants randomised to placebo, and those randomised to the 192 
three active interventions. Descriptive statistics were used to describe the condition at short 193 
and long term follow-up. 194 
 195 
Potential prognostic variables, including baseline values, were entered into multivariate 196 
backward stepwise linear regression analyses for each of the outcomes of PRTEE and PPT at 197 
both two and 12 months, in a manner consistent with previous study.35  Variables with the 198 
highest p values were removed one at a time, until all remaining variables were significant at 199 
p<0.10. Associations within each multivariate model were regarded as significant at p≤0.05. 200 
The strength of the predictive ability of identified factors in each multivariate model was 201 
evaluated by unstandardised regression coefficients (β) with 95% confidence intervals. 202 
Standardised regression coefficients were also reported to determine which of the 203 
independent variables had a greater effect on the dependent variable. Overall performance of 204 
the final models was evaluated with Nagelskerke’s R2, which estimates the percentage of 205 
explained variation of the model. 206 
 207 
Results  208 
Of the 41 participants assigned to placebo, one participant did not receive the saline injection, 209 
because felt recovered. Baseline demographic and symptomatic characteristics were 210 
comparable between participants assigned to placebo (n=41) and the overall randomised 211 
controlled trial population (n=165) (Table 1). All placebo-assigned participants were 212 
followed up at two months and 40/41 (98%) could be contacted at one year. During the one 213 
year follow up, oral analgesic or nonsteroidal anti-inflammatory medication was used by 39% 214 
(16/41) of participants, while 15% (6/41) sought additional medical consultations.  215 
 216 
Predictors of pain and disability 217 
Mean PRTEE scores improved from 41.6 ± 14.5 at baseline to 23.2 ± 13.5 at two months and 218 
5.2 ± 11.4 at 12 months. The multivariate model for PRTEE at two months revealed that 219 
greater baseline pain and disability (β  0.39, 95% CI 0.15 to 0.62), p=0.002) and greater cold 220 
hyperalgesia (β  0.77, 95% CI 0.21 to 1.33, p=0.008) were significantly associated with 221 
greater pain and disability (Table 2). The model explained 35% of the total variance, with 222 
baseline PRTEE having greater relative effect on the outcome. The 12 month multivariate 223 
model  found  greater  cold  hyperalgesia  (β  0.61, 95% CI 0.05 to 1.17, p=0.034) was the only 224 
factor significantly associated with greater pain and disability, explaining 9% of the total 225 
variance (Table 2).  226 
Predictors of mechanical hyperalgesia 227 
Mean PPT (kPa) at the affected elbow improved from 273.5 ± 130.5 at baseline to 351.4 ± 228 
140.7 at two months and 462.1 ± 199.7 at 12 months. Multivariate analysis (Table 3) revealed 229 
greater hyperalgesia was found at two months in females (β -149.83, 95% CI -222.38 to -230 
77.28, p<0.001) with greater cold hyperalgesia (β -6.19, 95% CI -11.98 to -0.39, p=0.037). 231 
The model explained 46% of the total variance, with female sex having a greater relative 232 
effect on the outcome. The 12 month multivariate model (Table 3) showed female  sex  (β  -233 
177.98, 95% CI  -285.7 to -70.26 , p=0.002) and greater cold  hyperalgesia  (β  -8.45, 95% CI -234 
16.8 to -0.09, p=0.048), as well as baseline PPT (β 0.39, 95% CI 0.01 to 0.77, p=0.046) were 235 
independent predictors of greater long term mechanical hyperalgesia. This model explained 236 
50% of the total variance. Of these independent predictors, female sex had the greatest effect 237 
on PPT, followed by cold pain threshold, with baseline PPT values having the least 238 
prognostic influence. 239 
 240 
 241 
Discussion 242 
This exploratory study of 41 placebo-assigned participants with unilateral LE is the first to 243 
show that the presence of cold hyperalgesia is associated with greater short term and long 244 
term pain and disability, as well as hyperalgesia to mechanical stimuli. In combination with 245 
baseline PRTEE scores, it explained approximately one third of the variance in pain and 246 
disability at two months. In the long term, it was the only significant predictor of pain and 247 
disability, although explained only a small proportion (9%) of the variability. Secondly, the 248 
results demonstrate that mechanical hyperalgesia persists at the affected elbow in women 249 
with cold hyperalgesia, independent of baseline PPT values. At one year, over half the 250 
variability in mechanical hyperalgesia could be explained by baseline cold hyperalgesia and 251 
gender.  252 
Cold hyperalgesia is emerging as an important indicator of poorer recovery in other 253 
musculoskeletal conditions such as whiplash.4, 14, 36 Cold pain threshold of >13⁰C was found 254 
to increase the risk of developing chronic moderate to severe pain and disability by 26-fold in 255 
individuals with whiplash (odds ratio 95% CI 5.0 to 139.1).37 We previously reported mean 256 
cold pain thresholds over the affected elbow of 13.7⁰C in LE participants with severe pain 257 
and disability (PRTEE>54), which was significantly greater than a healthy control population 258 
(mean 7.6⁰C).8 The mechanisms underlying cold hyperalgesia following injury are only 259 
partially understood, but may include altered processing by second order spinal cord sensory 260 
neurons or by changes in ion channel expression at peripheral cold-specific fiber terminals.38  261 
 262 
Considerable variability is found on review of studies investigating prognostic factors for LE, 263 
with methodological weaknesses and low sample sizes likely contributing to this.3 Consistent 264 
with earlier studies of LE,23 and other musculoskeletal conditions,39 we found baseline scores 265 
to predict short term recovery of pain and disability. However, we did not find an association 266 
between duration and pain and disability, as was found by other studies of LE.23, 40 Unlike 267 
two of these studies,25, 40 we excluded patients with symptoms less than six weeks in duration, 268 
hence we cannot draw conclusions on the prognosis of acute LE. In our study population, 269 
psychological factors did not significantly influence either pain and disability or mechanical 270 
hyperalgesia at the elbow.  271 
 272 
Whilst significantly correlated, pain and disability and mechanical hyperalgesia likely 273 
represent different aspects of the health condition of LE, the latter proposed to be a composite 274 
of physiological and psychological features of the patient and the health problem, mediated 275 
by social aspects.15 In this study, females showed greater mechanical hyperalgesia, which is 276 
consistent with findings from pain-free populations,24 whilst pain and disability was 277 
comparable between the sexes. Of note, only a small proportion (9%) of the variability in 278 
long term pain and disability was explained by the prognostic factors examined here. Despite 279 
a much larger sample size (n=349), Smidt (2006) also found the final set of predictors 280 
accounted for a low proportion (11%) of the variability in pain severity at one year.23 As such 281 
there may be other important predictive factors that were not measured in these studies, or 282 
alternatively it might not be possible to predict outcomes after one year for LE. We evaluated 283 
the prognostic capacity of QST measured at the affected elbow, while investigation of 284 
hyperalgesia at widespread sites or using other measures of central hypersensitivity, such as 285 
the nociceptive withdrawal reflex, may have allowed greater insight and speculation of the 286 
mechanisms involved in chronic pain development.  287 
 288 
Strengths and limitations 289 
The major strengths of this study are its methodological rigor, including high retention of 290 
participants and use of valid and reliable psychometric instruments to study pain processing 291 
combined with a psychological perspective. However, given the relatively small number of 292 
subjects in relation to the statistical requirements of prognostic investigation, this study 293 
should be considered exploratory. This study represents a secondary analysis of data from a 294 
randomised controlled trial, where predictive models were examined only in placebo-295 
assigned individuals. Whilst avoiding confounding associated with significant effects of 296 
corticosteroid injection and physiotherapy, it should be acknowledged that administration of a 297 
blinded placebo injection might cause treatment expectations.41 However, recovery profiles 298 
were remarkably similar to previous studies in which 27% 42 and 32%43 of patients assigned 299 
to a wait and see policy reported being completely recovered or much improved after six 300 
weeks, compared 29% of patients assigned to placebo at eight weeks in our study. Similar 301 
recovery was also seen at one year, with 92.5% of placebo injected patients and 87% of those 302 
assigned to a wait and see approach44 being completely recovered or much improved. 303 
Nonetheless, results should be viewed as preliminary until replication in other LE populations 304 
is undertaken.  305 
 306 
 307 
Implications for clinical practice and future research 308 
Although obviously in need of further confirmation, the results provide preliminary 309 
suggestions for clinical practice and future research. Assessment of cold pain thresholds may 310 
assist early identification of altered pain processing that is associated with higher risk for 311 
chronic pain development. The presence of cold hyperalgesia, particularly in LE patients with 312 
greater pain and disability, warrants early intervention targeted toward effective control of 313 
nociceptive input, and for example, might distinguish those who may benefit from more 314 
centrally acting analgesics. Considerable research is needed before the clinical utility of this 315 
measure can be realised. In addition to validation of these findings, further research is needed 316 
to determine thresholds for cold hyperalgesia and explore whether the described changes in 317 
pain processing recover or persist over time.  318 
 319 
 320 
Conclusion 321 
Assessment of cold pain thresholds might be a valuable clinical tool to help identify patients 322 
with LE at risk of poorer prognosis. This study sheds early insight into the mechanisms 323 
underlying the development of chronic pain associated with LE and may provide direction for 324 
mechanism-based therapeutic and preventative approaches.  325 
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  332 
Table 1: Baseline characteristics for participants assigned to placebo (saline injection, n=41) or 333 
active interventions (corticosteroid injection, physiotherapy or both, n=124).  334 
Only data from the placebo group was analysed in this prognostic evaluation. No baseline 335 
differences were found between placebo and intervention groups. Values are mean ± SD or count 336 
(%). PRTEE: Patient-rated tennis elbow evaluation, HADS: Hospital anxiety and depression scale, TSK: 337 
Tampa scale of kinesiophobia. 338 
 339 
  340 
Table 2: Prognostic indicators of pain and disability as measured with the Patient Rated Tennis 341 
Elbow Evaluation (PRTEE) questionnaire at 2 and 12 months. 342 
Standardised coefficient and unstandardised regression coefficient (ß) and its 95% confidence 343 
interval (CI). ß positive refers to more pain and disability per unit potential prognostic indicator and 344 
ß negative indicates less pain and disability per unit potential prognostic indicator. Adjusted R2 345 
represents the proportion of the total variance explained by the final model. CPT: cold pain 346 
threshold; PPT: Pressure pain threshold; PFG: pain free grip; TSK: Tampa scale of kinesiophobia; 347 
HADS: Hospital anxiety and depression scale. 348 
 349 
  350 
Table 3: Prognostic indicators of mechanical hyperalgesia as measured by pressure pain threshold 351 
(PPT) at the elbow at 2 and 12 months. 352 
Standardised coefficient and unstandardised regression coefficient (ß) and its 95% confidence 353 
interval (CI). ß positive refers to less hyperalgesia (higher PPT) per unit potential prognostic indicator 354 
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Table 1: Baseline characteristics for participants assigned to placebo (saline injection, n=41) or 
active interventions (corticosteroid injection, physiotherapy or both, n=124).  
Only data from the placebo group was analysed in this prognostic evaluation. No baseline 
differences were found between placebo and intervention groups. Values are mean ± SD or count 
(%). PRTEE: Patient-rated tennis elbow evaluation, HADS: Hospital anxiety and depression scale, TSK: 
Tampa scale of kinesiophobia. 
 
Placebo  
n=41 
 
Intervention 
n=124 
Age (years) 49.9  ± 7.4 49.8 ± 7.9 
Sex (female %) 17 (41.5%) 46 (37.1%) 
Duration (weeks) 25.7  ± 28.7 25.0 ± 30.3 
PRTEE: Pain and disability (0-100) 41.6  ± 14.5 38.8  ± 13.9 
Pressure pain threshold (kPa) 273.5  ± 130.5 270.6 ± 118.0 
Cold  pain  threshold  (⁰C) 10.2  ± 6.2 11.9 ± 6.4 
Pain free grip (N) 79.9  ± 47.6 86.5 ± 50.0 
TSK: Kinesiophobia (11-44) 23.7  ± 4.8 24.5 ± 5.2 
HADS: Anxiety and Depression (0-42) 7.6 ± 4.8 6.2 ± 3.8 
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Table 2: Prognostic indicators of pain and disability as measured with the Patient Rated Tennis 
Elbow Evaluation (PRTEE) questionnaire at 2 and 12 months. 
Standardised coefficient and unstandardised regression coefficient (ß) and its 95% confidence 
interval (CI). ß positive refers to more pain and disability per unit potential prognostic indicator and 
ß negative indicates less pain and disability per unit potential prognostic indicator. Adjusted R2 
represents the proportion of the total variance explained by the final model. CPT: cold pain 
threshold; PPT: Pressure pain threshold; PFG: pain free grip; TSK: Tampa scale of kinesiophobia; 
HADS: Hospital anxiety and depression scale. 
  8 weeks       52 weeks     
Variables 
Standardised  
coefficients 
Unstandardised 
coefficients (95%CI) p   
Standardised  
coefficients 
Unstandardised 
coefficients (95%CI) p 
Intercept   -0.66 (-11.54, 10.21) 0.90     -1.28 (-8.00, 5.43) 0.70 
Female gender               
Duration, per week               
PRTEE, per point 0.431 0.39 (0.15, 0.62) 0.002         
CPT,  per  ⁰C 0.364 0.77 (0.21, 1.33) 0.008   0.335 0.61 (0.05, 1.17) 0.034 
PPT, per KPa               
PFG, per N               
TSK, per point               
HADS, per point               
Adjusted R2      0.35       0.09 
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Table 3: Prognostic indicators of mechanical hyperalgesia as measured by pressure pain threshold 
(PPT) at the elbow at 2 and 12 months. 
Standardised coefficient and unstandardised regression coefficient (ß) and its 95% confidence 
interval (CI). ß positive refers to less hyperalgesia (higher PPT) per unit potential prognostic indicator 
and ß negative indicates more hyperalgesia (lower PPT) per unit potential prognostic indicator. 
Adjusted R2 represents the proportion of the total variance explained by the final model. PRTEE: 
Patient rated tennis elbow evaluation; CPT: cold pain threshold; PPT: Pressure pain threshold; PFG: 
pain free grip; TSK: Tampa scale of kinesiophobia; HADS: Hospital anxiety and depression scale. 
 
8 weeks       52 weeks     
Variables 
Standardised  
coefficients 
Unstandardised 
coefficients (95%CI) p   
Standardised  
coefficients 
Unstandardised 
coefficients (95%CI) p 
Intercept   470.80 (407.46, 534.15) <0.001     583.04 (390.88 775.19) <0.001 
Female gender -0.538 -149.83 (-222.38, -77.28) <0.001   -0.442 -177.98 (-285.7, -70.26) 0.002 
Duration, per week               
PRTEE, per point               
CPT,  per  ⁰C -0.277 -6.19 (-11.98, -0.39) 0.037   -0.265 -8.45 (-16.80, -0.09) 0.048 
PPT, per KPa         0.259 0.39 (0.01, 0.77) 0.046 
PFG, per N               
TSK, per point               
HADS, per point         -0.210 -8.78 (-18.91, 1.35) 0.087 
Adjusted R2      0.46       0.52 
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